Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer

摘要

With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer,there has come a need to discriminate responders from non-responders.In this article,the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.